Caregen (A214370) Stock Overview

A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide. More details

A214370 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends1/6

A214370 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Caregen Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Caregen
Historical stock prices
Current Share Price₩36,500.00
52 Week High₩38,200.00
52 Week Low₩14,850.00
Beta0.48
1 Month Change8.47%
3 Month Change39.85%
1 Year Change58.01%
3 Year Change87.76%
5 Year Change201.16%
Change since IPO70.56%

Recent News & Updates

Caregen's (KOSDAQ:214370) Problems Go Beyond Weak Profit

May 22
Caregen's (KOSDAQ:214370) Problems Go Beyond Weak Profit

Recent updates

Caregen's (KOSDAQ:214370) Problems Go Beyond Weak Profit

May 22
Caregen's (KOSDAQ:214370) Problems Go Beyond Weak Profit

Caregen Co., Ltd. (KOSDAQ:214370) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Mar 08
Caregen Co., Ltd. (KOSDAQ:214370) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

A Look At The Fair Value Of Caregen Co., Ltd. (KOSDAQ:214370)

Jan 20
A Look At The Fair Value Of Caregen Co., Ltd. (KOSDAQ:214370)

Earnings Not Telling The Story For Caregen Co., Ltd. (KOSDAQ:214370) After Shares Rise 29%

Dec 20
Earnings Not Telling The Story For Caregen Co., Ltd. (KOSDAQ:214370) After Shares Rise 29%

Why Caregen's (KOSDAQ:214370) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 21
Why Caregen's (KOSDAQ:214370) Shaky Earnings Are Just The Beginning Of Its Problems

Why We're Not Concerned Yet About Caregen Co., Ltd.'s (KOSDAQ:214370) 26% Share Price Plunge

Aug 06
Why We're Not Concerned Yet About Caregen Co., Ltd.'s (KOSDAQ:214370) 26% Share Price Plunge

Caregen (KOSDAQ:214370) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Mar 18
Caregen (KOSDAQ:214370) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

With Caregen Co., Ltd. (KOSDAQ:214370) It Looks Like You'll Get What You Pay For

Mar 05
With Caregen Co., Ltd. (KOSDAQ:214370) It Looks Like You'll Get What You Pay For

A Look At The Fair Value Of Caregen Co., Ltd. (KOSDAQ:214370)

Apr 20
A Look At The Fair Value Of Caregen Co., Ltd. (KOSDAQ:214370)

Here's How We Evaluate Caregen Co., Ltd.'s (KOSDAQ:214370) Dividend

Mar 02
Here's How We Evaluate Caregen Co., Ltd.'s (KOSDAQ:214370) Dividend

Caregen (KOSDAQ:214370) Is Growing Earnings But Are They A Good Guide?

Feb 04
Caregen (KOSDAQ:214370) Is Growing Earnings But Are They A Good Guide?

Do Its Financials Have Any Role To Play In Driving Caregen Co., Ltd.'s (KOSDAQ:214370) Stock Up Recently?

Jan 14
Do Its Financials Have Any Role To Play In Driving Caregen Co., Ltd.'s (KOSDAQ:214370) Stock Up Recently?

Caregen Co., Ltd. (KOSDAQ:214370) Goes Ex-Dividend Soon

Dec 25
Caregen Co., Ltd. (KOSDAQ:214370) Goes Ex-Dividend Soon

Do Insiders Own Lots Of Shares In Caregen Co., Ltd. (KOSDAQ:214370)?

Dec 10
Do Insiders Own Lots Of Shares In Caregen Co., Ltd. (KOSDAQ:214370)?

Is Caregen Co., Ltd. (KOSDAQ:214370) A Great Dividend Stock?

Nov 19
Is Caregen Co., Ltd. (KOSDAQ:214370) A Great Dividend Stock?

Shareholder Returns

A214370KR PharmaceuticalsKR Market
7D0%1.5%0.7%
1Y58.0%-2.6%4.9%

Return vs Industry: A214370 exceeded the KR Pharmaceuticals industry which returned -2.6% over the past year.

Return vs Market: A214370 exceeded the KR Market which returned 4.9% over the past year.

Price Volatility

Is A214370's price volatile compared to industry and market?
A214370 volatility
A214370 Average Weekly Movement11.5%
Pharmaceuticals Industry Average Movement4.5%
Market Average Movement6.0%
10% most volatile stocks in KR Market12.1%
10% least volatile stocks in KR Market3.0%

Stable Share Price: A214370's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A214370's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
2001192Yong-Ji Jeongcaregen.co.kr

Caregen Co., Ltd., a biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide. The company offers filler products under the REVOFIL, DR CYJ, PROSTROLANE, PROSTROLANE B-Series, and CG Styler 600 names; skin care products under the Dermaheal, PURILUX whitening, Pim-Pim-Paul, and Neovert names; scalp care products under the Renokin and Pelo Baum names; and healthy foods under the proGsterol name.

Caregen Co., Ltd. Fundamentals Summary

How do Caregen's earnings and revenue compare to its market cap?
A214370 fundamental statistics
Market cap₩1.78t
Earnings (TTM)₩31.22b
Revenue (TTM)₩83.43b
57.1x
P/E Ratio
21.4x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A214370 income statement (TTM)
Revenue₩83.43b
Cost of Revenue₩27.69b
Gross Profit₩55.74b
Other Expenses₩24.52b
Earnings₩31.22b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)638.86
Gross Margin66.81%
Net Profit Margin37.42%
Debt/Equity Ratio0%

How did A214370 perform over the long term?

See historical performance and comparison

Dividends

1.8%
Current Dividend Yield
100%
Payout Ratio

Does A214370 pay a reliable dividends?

See A214370 dividend history and benchmarks
When do you need to buy A214370 by to receive an upcoming dividend?
Caregen dividend dates
Ex Dividend DateJun 27 2025
Dividend Pay DateJul 17 2025
Days until Ex dividend13 days
Days until Dividend pay date7 days

Does A214370 pay a reliable dividends?

See A214370 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/09 00:20
End of Day Share Price 2025/07/09 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Caregen Co., Ltd. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Byung Hwa HanEugene Investment & Securities Co Ltd.
Brian ChoHSBC
Sang-Hun LeeiM Securities